API Intermediates
API intermediates are the essential chemical compounds formed during the synthesis of Active Pharmaceutical Ingredients (APIs). These intermediates play a critical role in defining the purity, efficacy, and overall quality of the final pharmaceutical product. Produced under strict regulatory compliance, API intermediates must meet rigorous quality standards to ensure they are safe and effective for further formulation.
API Intermediates Products
| SL NO. | NAME OF THE PRODUCT | CAS NO. | API |
|---|---|---|---|
| 1 | 2-Butylbenzofuran | 4265-27-4 | Amiodarone |
| 2 | 5-Chlorovaleryl Chloride | 1575-61-7 | Apixaban |
| 3 | 3,3-Dichloro-1-(4-nitrophenyl) piperidin-2-one | 881386-01-2 | Apixaban |
| 4 | 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 536760-29-9 | Apixaban |
| 5 | 5-Bromovaleryl Chloride | 4509-90-4 | Apixaban |
| 6 | 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | 545445-44-1 | Apixaban |
| 7 | 2-Chloro-5-Iodobenzoic Acid | 19094-56-5 | Empagliflozin / Bexagliflozin / Dapagliflozin / Sotagliflozin |
| 8 | (2-Chloro-5-iodophenyl)(4-fluorophenyl) methanone | 915095-86-2 | Empagliflozin |
| 9 | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 | Empagliflozin |
| 10 | 5-Bromo-2-Chlorobenzoic Acid | 21739-92-4 | Dapagliflozin / Empagliflozin |
| 11 | (5-Bromo-2-chlorophenyl)(4-ethoxyphenyl) methanone | 461432-22-4 | Dapagliflozin / Sotagliflozin |
| 12 | 5-Bromo-2-chloro-4-ethoxydiphenylmethane | 461432-23-5 | Dapagliflozin / Sotagliflozin |
| 13 | 5-Iodo-2-chloro-4’-ethoxydiphenylmethanone | 1103738-26-6 | Dapagliflozin |
| 14 | 5-Iodo-2-chloro-4’-ethoxydiphenylmethane | 1103738-29-9 | Dapagliflozin |
| 15 | 2-Methyl-5-Iodobenzoic Acid | 54811-38-0 | Canagliflozin |
| 16 | L-Threonine Methyl Ester HCl | 39994-75-7 | Insulin |
| 17 | Iodobenzene | 591-50-4 | Pirfenidone |
| 18 | Chloroiodomethane | 593-71-5 | Vaniprevir |
| 19 | Diiodomethane | 75-11-6 | Etravirine |
| 20 | 1-Bromo-2-iodobenzene | 583-55-1 | Vortioxetine |
| 15 | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 | Rivaroxaban |
API Intermediates - Under Scale Up Products
| SL NO. | NAME OF THE PRODUCT | CAS NO. | API |
|---|---|---|---|
| 1 | p-Toluenesulfonylmethyl Isocyanide | 36635-61-7 | Bempedoic Acid |
| 2 | (3S)-3-[4-[(2-Chloro-5-iodophenyl) methyl] phenoxy] tetrahydro-furan | 915095-94-2 | Empagliflozin |
| 3 | S)-3-(4-(5-Bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran | 915095-89-5 | Empagliflozin |
| 4 | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 | Dapagliflozin / Empagliflozin |
| 5 | 6-Nitro-1H-indazole | 7597-18-4 | - |
| 6 | 4-iodobenzonitrile | 3058-39-7 | - |
API Intermediates - Under Development Products
| SL NO. | NAME OF THE PRODUCT | CAS NO. | API |
|---|---|---|---|
| 1 | 4-Bromo-2-Chlorobenzonitrile | 154607-01-9 | Darolutamide |
| 2 | Ethyl-7-Bromo-2,2-Dimethylheptanoate | 123469-92-1 | Bempedoic Acid |
| 3 | 2,2,14,14-tetramethyl-8-oxopentadecaenedioic | 413624-71-2 | Bempedoic Acid |
| 4 | 6-Iodo-1H-Indazole | 261953-36-0 | Axitinib |
| 5 | 3-iodo-6-nitro-1-(tetrahydro-2-Hpyran-2-yl)-1H-indazole | 886230-74-6 | Axitinib |
| 6 | (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole | 886230-77-9 | Axitinib |
| 7 | 2,3,4,6-Tetra-O-Benzyl-D-Glucopyranose | 4132-28-9 | Miglustat |
| 8 | 3-(piperidin-4-yl)quinolin-2(1h)-one hydrochloride | 855778-84-6 | Zavegepant |
| 9 | 1-(1-Methylpiperidin-4-yl)piperazine trihydrochloride | 349535-15-5 | Zavegepant |
| 10 | 1-(1-Methylpiperidin-4-yl)piperazine | 23995-88-2 | Zavegepant |
| 11 | (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl) tetrahydro-2H-pyran-3,4,5-triyl triacetate | 915095-99-7 | Empagliflozin |
| 12 | 2-Chloro-3-iodo-4-pyridinamime | 909036-46-0 | - |